These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1263513)

  • 1. Binding of agonists and antagonists to muscarinic receptors.
    Birdsall NJ; Burgen AS; Hiley CR; Hulme EC
    J Supramol Struct; 1976; 4(3):367-71. PubMed ID: 1263513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical studies on muscarinic receptors.
    Massoulié J; Godwin S; Carson S; Kato G
    Biomedicine; 1977 Jul; 26(4):250-9. PubMed ID: 579159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The theory, methods and relevance of muscarinic receptor binding studies.
    Stockton J; Birdsall NJ; Burgen AS; Hulme EC
    Scand J Gastroenterol Suppl; 1982; 72():43-7. PubMed ID: 6957996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification and characterization of a muscarinic acetylcholine receptor from rat cerebral cortex.
    Bartfai T; Anner J; Schultzberg M; Montelius J
    Biochem Biophys Res Commun; 1974 Jul; 59(2):725-33. PubMed ID: 4853542
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
    Martino-Barrows AM; Kellar KJ
    Mol Pharmacol; 1987 Feb; 31(2):169-74. PubMed ID: 3807893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties.
    Marchi M; Raiteri M
    J Pharmacol Exp Ther; 1985 Oct; 235(1):230-3. PubMed ID: 3840202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptors in mammalian brain: differences between bindings of acetylcholine and atropine.
    Uchida S; Takeyasu K; Ichida S; Yoshida H
    Jpn J Pharmacol; 1978 Dec; 28(6):853-62. PubMed ID: 745309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the binding properties of muscarinic receptors by gallamine.
    Stockton JM; Birdsall NJ; Burgen AS; Hulme EC
    Mol Pharmacol; 1983 May; 23(3):551-7. PubMed ID: 6865905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.
    Thor D; Schulz A; Hermsdorf T; Schöneberg T
    Biochem J; 2008 May; 412(1):103-12. PubMed ID: 18237275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.